LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 74.97 | 17.25 | 8725 | 5618 | 1.5528 | 1.1083 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 76.94 | 17.25 | 291 | 5681 | 0.0512 | 0.4019 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 76.94 | 17.25 | 8398 | 5681 | 1.4781 | 1.0957 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 76.94 | 17.25 | 13 | 5681 | 0.0023 | -0.0333 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 76.94 | 17.25 | 8965 | 5681 | 1.5779 | 1.1121 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 78.91 | 17.25 | 247 | 5730 | 0.0431 | 0.3740 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 78.91 | 17.25 | 8630 | 5730 | 1.5060 | 1.1002 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 78.91 | 17.25 | 3 | 5730 | 0.0005 | -0.1885 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 78.91 | 17.25 | 9258 | 5730 | 1.6155 | 1.1179 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 80.88 | 17.25 | 163 | 5826 | 0.0280 | 0.3065 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 80.88 | 17.25 | 8716 | 5826 | 1.4960 | 1.0983 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 80.88 | 17.25 | 4 | 5826 | 0.0007 | -0.1597 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 80.88 | 17.25 | 9467 | 5826 | 1.6249 | 1.1190 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 82.85 | 17.25 | 206 | 5861 | 0.0351 | 0.3430 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 82.85 | 17.25 | 8872 | 5861 | 1.5136 | 1.1011 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 82.85 | 17.25 | 5 | 5861 | 0.0009 | -0.1370 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 82.85 | 17.25 | 9714 | 5861 | 1.6572 | 1.1238 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 84.82 | 17.25 | 145 | 5924 | 0.0245 | 0.2875 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 84.82 | 17.25 | 9001 | 5924 | 1.5194 | 1.1018 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 84.82 | 17.25 | 1 | 5924 | 0.0002 | -0.2869 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 84.82 | 17.25 | 9909 | 5924 | 1.6726 | 1.1259 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 86.79 | 17.25 | 82 | 6008 | 0.0136 | 0.2027 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 86.79 | 17.25 | 9040 | 6008 | 1.5046 | 1.0991 | MN20160310_N02 | E06 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 86.79 | 17.25 | 1 | 6008 | 0.0002 | -0.2863 | MN20160310_N02 | I11 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.031667 | 86.79 | 17.25 | 10070 | 6008 | 1.6760 | 1.1261 | MN20160310_N02 | I11 |